Actively Recruiting

Phase 4
Age: 19Years - 50Years
All Genders
Healthy Volunteers
NCT06135636

Assessing Interventions to Increase Tdap Acceptance for Non-birthing Partners in Pregnancy

Led by Women and Infants Hospital of Rhode Island · Updated on 2024-09-20

150

Participants Needed

1

Research Sites

56 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

The goal of this randomized control trial is to assess if prenatal vaccine education and in-office vaccination administration for non-birthing partners of pregnant patients increases Tdap vaccination rates compared to usual care. The main question\[s\] it aims to answer are: * To assess whether compared to standard prenatal care, targeted prenatal education regarding Tdap vaccination recommendations with and without in office vaccination opportunities improves Tdap uptake among non-birthing partners of pregnant patients. * To assess whether non-birthing partners presenting for Tdap vaccination are willing to accept dual vaccination with Tdap and influenza. Participants will receive direct verbal and written education at the time of enrollment on cocooning and recommendation for partner Tdap vaccination prior to delivery with or without the option to receive Tdap at their convenience at the WIH obstetric care clinic. If there is a comparison group: Researchers will compare "Upfront Education" and "Upfront Education and Vaccination Administration" to "Usual care" to see if education and/or the offer for vaccination in the office increases Tdap vaccine acceptance for non-birthing partners.

CONDITIONS

Official Title

Assessing Interventions to Increase Tdap Acceptance for Non-birthing Partners in Pregnancy

Who Can Participate

Age: 19Years - 50Years
All Genders
Healthy Volunteers

Eligibility Criteria

Eligible

You may qualify if you...

  • Be the partner of a pregnant patient receiving prenatal care at the OGCC
  • Be between 19 and 50 years old
  • Have not received or be unsure if you received the adult Tdap vaccine or booster in the last 10 years
  • Be fluent in English or Spanish
Not Eligible

You will not qualify if you...

  • Have a latex allergy
  • Have a lethal fetal anomaly diagnosed before enrollment

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Women and Infants Hospital

Providence, Rhode Island, United States, 02920

Actively Recruiting

Loading map...

Research Team

L

Laurie Griffin, MD/PhD

CONTACT

A

Adam Lewkowitz, MD/MPHS

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

HEALTH_SERVICES_RESEARCH

Number of Arms

3

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here